Jiangbo Pharma’s Bone Drug Included in Basic Medical Directory

Jiangbo Pharmaceuticals reported its oral Osteomyelitis treatment, Kang Gu Sui Yan Pian, has been included in the 2009 Edition of the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Medicine Directory. The product is not a significant revenue-producer for Jiangbo, but we look at the four pharmaceuticals that generate 96% of the company's revenues. More details... Stock Symbol: (OTCBB: JGBO)